Psykey, Inc. CEOS OTC

Psykey, Inc. (CEOS) reported total assets of $4.12M and total liabilities of $5.14M for fiscal year 2024, resulting in total equity of $-1.02M.

The company held $2.27M in cash and short-term investments. Total debt stood at $1.22M, with net debt of $-1.05M. The Debt-to-Equity (D/E) ratio was -1.2 (conservative).

Current ratio is 0.56, which may signal tight short-term liquidity. Interest coverage is -10.8x (weak).

Criteria supported by this page:

• HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (50/100) — Total assets $4.12M and equity $-1.02M support the company's competitive scale

Overall SharesGrow Score: 22/100 with 0/7 criteria passed.

UTMD

Utah Medical Products, Inc.

$68.80

+0.63%

STSS

Sharps Technology, Inc.

$1.85

+6.32%

ZJYL

Jin Medical International Ltd.

$2.12

-0.47%

NXGL

NEXGEL, Inc.

$0.76

+27.12%

LUCY

Innovative Eyewear, Inc.

$1.09

+0.93%

BNGO

Bionano Genomics, Inc.

$1.28

+5.79%

POAI

Predictive Oncology Inc.

$3.50

+0.86%

GMVD

G Medical Innovations Holdings Ltd

$0.18

+1.38%